Retail sale of pharmaceutical products
APOVEST AS
Revenue 2024
NOK 2.9m
Operating profit
NOK 123,000
Equity
NOK 5.0m
Incorporated
2009
Share capital
NOK 2.5m
Key figures · 2025
Current ratio
0.17
Equity ratio
41.7%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 4.2% | |
| Net margin (%%) | -1.8% | |
| Return on assets (%%) | 1.0% | |
| Likviditet | ||
| Current ratio | 0.17 | |
| Working capital | −3.3m | |
| Soliditet | ||
| Equity ratio (%%) | 41.7% | |
| Debt-to-equity ratio | 1.40 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.